Quantcast

RAPS Virtual Program on Advertising, Promotion and Labeling for Drugs and Devices to Cover FTC and FDA Enforcement, Social Media, Sunshine Act and More

April 23, 2013

RAPS will host a virtual workshop featuring regulators and regulatory experts on current communications guidelines and expectations for companies marketing regulated healthcare products in the US.

Rockville, MD, USA (PRWEB) April 23, 2013

The Regulatory Affairs Professionals Society (RAPS) will host a virtual workshop, Advertising, Promotion and Labeling: the US Regulated Environment, Monday, 29 April, 12:00—5:00 pm EDT. The program features regulators and regulatory experts on current communications guidelines and expectations for companies marketing regulated healthcare products in the US.

Among the program´s speakers is Richard L. Cleland, assistant director, Division of Advertising Practices, for the Federal Trade Commission (FTC), who will present a case study examining ad interpretation and scientific substantiation for regulated products, and an analysis of recent legal rulings.

The workshop also will cover false claims enforcement activities by both FTC and the US Food and Drug Administration (FDA); direct-to-consumer marketing; the use of social media to discuss biologics, drugs and medical devices; regulatory´s role in managing intended use and off-label promotion; and a look at how the new Sunshine Act affects promotional activities.

Other expert speakers on the agenda include Carol Cooper, MS, RAC, associate director of regulatory affairs in regulatory operations and compliance at Baxter Healthcare; Stefanie Doebler, JD, MPH, MA, special counsel in Covington & Burling LLP; and Bradley Merrill Thompson, JD, MBA, RAC, attorney, Epstein Becker & Green PC, and strategic counsel with EBG Advisors Inc.

Advance registration is open through 24 April. Interested members of the media should contact RAPS Senior Manager of Communications Zachary Brousseau.

About RAPS

The Regulatory Affairs Professionals Society (RAPS) is the largest global organization of and for those involved with the regulation of healthcare and related products, including medical devices, pharmaceuticals, biologics and nutritional products. Founded in 1976, RAPS helped establish the regulatory profession and continues to actively support the professional and lead the profession as a neutral, non-lobbying nonprofit organization. RAPS offers education and training, professional standards, publications, research, knowledge sharing, networking, career development opportunities and other valuable resources, including Regulatory Affairs Certification (RAC), the only post-academic professional credential to recognize regulatory excellence. RAPS is headquartered in suburban Washington, DC, with offices in Europe and Asia, and chapters and affiliates worldwide. RAPS.org

###

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2013/4/prweb10662118.htm


Source: prweb



comments powered by Disqus